Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome Original paper
-
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Recent research has focused on the gut microbiota's role in IBS, aiming to identify specific microbial signatures associated with the condition.
-
Kimberly Eyer
Kimberly Eyer, a Registered Nurse with 30 years of nursing experience across diverse settings, including Home Health, ICU, Operating Room Nursing, and Research. Her roles have encompassed Operating Room Nurse, RN First Assistant, and Acting Director of a Same Day Surgery Center. Her specialty areas include Adult Cardiac Surgery, Congenital Cardiac Surgery, Vascular Surgery, and Neurosurgery.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Karen Pendergrass
Location
United States of America
Sample Site
Feces
Species
Homo sapiens
What was studied?
The study explored the correlation between gut microbial composition and regional brain structural changes in patients with Irritable Bowel Syndrome (IBS). Specifically, it aimed to identify distinct subgroups of IBS patients based on gut microbial profiles and examine how these subgroups correlated with structural brain alterations, particularly in sensory integration and salience network regions. This study is the first of its kind to demonstrate a direct association between gut microbiota composition and brain architecture in IBS, offering insights into the gut-brain axis and its potential implications in IBS pathophysiology.
Who was studied?
The study included 29 adult IBS patients and 23 healthy controls (HCs). Among the IBS patients, distinct subgroups were identified: IBS1, which showed a unique gut microbial signature, and HC-like IBS, whose microbial composition resembled that of healthy controls. These participants underwent stool sample analysis for microbial profiling and structural brain imaging to assess regional brain volumes and correlating microbial taxa.
What were the most important findings?
The study identified two primary subgroups within the IBS population (IBS1 and HC-like IBS) based on gut microbial composition. The IBS1 subgroup exhibited significant differences in the relative abundance of certain microbial taxa, including higher levels of Clostridia and reduced levels of Bacteroidia, which were strongly associated with structural brain changes. Notably, IBS1 showed increased volumes in sensory and motor brain regions while experiencing reduced volumes in the insula and prefrontal cortices. These changes correlated with microbial diversity and the relative abundance of Firmicutes and Bacteroidetes, suggesting that distinct microbial clusters may influence sensory processing and brain structure in IBS patients. Furthermore, the findings indicated that early life trauma and long-standing symptoms were more prevalent in the IBS1 subgroup, hinting at the potential role of gut microbial metabolites in altering brain development and sensory integration pathways. The study suggests that IBS subgroups defined by microbial signatures, rather than traditional clinical classifications, could improve the personalization of therapeutic interventions.
| Parameter | Findings in IBS1 Group |
|---|---|
| Microbial Diversity | Higher alpha diversity and richness compared to HCs |
| Firmicutes and Bacteroidetes | Increased Firmicutes (Clostridia) and decreased Bacteroidetes (Bacteroidia) |
| Brain Structural Changes | Enlarged sensory and motor regions, reduced volumes in insula and prefrontal cortices |
| Sensory Integration Regions | Correlated with Clostridia abundance |
| Salience Network Regions | Altered structural changes linked to microbial composition |
| Early Life Trauma | More common in IBS1, potentially linked to gut-brain axis alterations |
| Therapeutic Implications | Suggests targeted microbial-based therapies for distinct IBS subtypes |
What are the greatest implications of this study?
The study’s findings underscore the potential for redefining IBS subtypes based on gut microbial composition rather than solely clinical characteristics. This microbial stratification could enable more targeted interventions, such as diet modification, prebiotics, probiotics, and antibiotic therapies, specifically tailored to the microbiome of the IBS1 subgroup. Additionally, the observed brain structural changes in sensory and salience-related regions support the hypothesis that gut microbiota play a role in the neurobiological mechanisms underlying IBS symptoms. These insights also point towards the gut-brain axis as a therapeutic target, where modulation of microbial communities could influence not only gastrointestinal symptoms but also associated neurological outcomes.
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Recent research has focused on the gut microbiota's role in IBS, aiming to identify specific microbial signatures associated with the condition.